BioXcel Therapeutics, Inc. Operating Leases, Future Minimum Payments, Due in Rolling after Year Five
BioXcel Therapeutics, Inc. (BTAI) had Operating Leases, Future Minimum Payments, Due in Rolling after Year Five of $468.00 thousand as of 2018-12-31, per its 10-K filed 2019-03-12.
Discontinued › Notes › Leases
us-gaap:OperatingLeasesFutureMinimumPaymentsDueInRollingAfterYearFive · last filed 2019-03-12
- 2018-12-31: Operating Leases, Future Minimum Payments, Due in Rolling after Year Five $468.00K.
- 2018-09-30: Operating Leases, Future Minimum Payments, Due in Rolling after Year Five $468.00K.
| Period end | Operating Leases, Future Minimum Payments, Due in Rolling after Year Five |
|---|---|
| 2018-12-31 | $468.00K 10-K · filed 2019-03-12 |
| 2018-09-30 | $468.00K 10-Q · filed 2018-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |